Print Page | Sign In | Join Today
THRIVE 2015 Program
Share |

Thrive: creating the future of bioscience in Virginia 




Please use #THRIVEinVA for discussion




Start Finish Information Location
8:00 AM 6:00 PM Registration Open Rotunda
8:00 AM 5:00 PM Exhibits Open Rotunda
9:00 AM 5:00 PM Virginia Bio Women Hospitality Westfields Lounge
9:00 AM 5:00 PM 1X1 Meetings with Federal Program Personnel and private funders Westfields Lounge
9:00 AM 10:50 AM Fueling bioscience innovation and commercialization Lincoln Forum

Strategies and introductions to federal grant makers for bioscience research and commercialization
- Colonel Todd Rasmussen, Director, Combat Casualty Research Program, DOD
- Susan Nichols, Program Director, Small Business Programs Office, DARPA
- Ruth Shuman, Program Director, National Science Foundation, Biological Technologies
- Patricia Weber, Program Director, National Cancer Institute
- Stephanie Fertig, Director Small Business Programs, National Institute of Neurological Disorders and Stroke
- Natialie Kruchinin, Small Business Program Coordinator, RTSP, DEA, National Institute of Allergy and Infectious Disease
Moderator - Liz Powell, Founder and Principal, G2G Consulting

Moderator - Robert Brooke, Director Federal Funding Programs, Center for Innovative Technology
9:00 AM 10:50 AM Statewide Roundtable on Bio and Economic Development Washingtonian II

Local and Regional Developments and Best Practices

- Anne Rosenblum, Fairfax County Economic Development, Moderator

- Christy Blake, Loudoun County Economic Development

- Douglas Corrigan, Southern Virginia Product Advancement Center

- David Couch, Virginia Beach Economic Development

- Leigh Cockram, Institute for Advanced Learning and Research

- Grace Festa, Greater Richmond Partnership

- Jeff Kaczmarek, Prince William County Economic Development

- Carrie Roth, Virginia BioTechnology Research Park

- Tim Stuller, Virginia Economic Development Partnership

- all other economic development professionals in attendance

Outlook on developments in state public policy: Governor McAuliffe's Bioscience Initiative - Dr. Jennifer Lee, Deputy Secretary Health and Human Resources, Office of Governor Terry McAuliffe
9:00 AM 10:50 AM Heads up: Changing federal laws impacting how bioscience innovation is developed and approved Washingtonian I

Reinventing the FDA - Twenty First Century Cures Initiative

The Innovation Act of 2015: the impact on bioscience of more changes to US Patent law?

Medical Device Excise Tax: impact on innovation, and update on the move to repeal

- Congressman Morgan Griffith, R-VA 9th, Member of the House Energy and Commerce Committee

- Adam Harbison, Legislative Director, Office of Congressman Griffith

- Wanda Moebius, Senior Vice President, Public Affairs, AdvaMed

- Anna Weinstein, Director Federal Government Relations, BIO

- Paul Price, Senior Consultant, Biologics Consulting Group, Inc.
10:50 AM 11:00 AM Networking Break Rotunda
11:00 12:00 Fueling bioscience innovation and commercialization - continued Lincoln Forum

Perspectives from private funders

- Isai Peimer, Managing Director, MedImmune Ventures, Inc.

- Jill Carroll, Sr. Associate, SR One

- Mike Grisham, CEO, The Catalyst, Virginia Bioscience Health Research Corporation
11:00 12:00 Statewide Roundtable on Bio and Economic Development - continued Washingtonian II

A conversation on consideration of bioscience companies in relocation and investment

Moderator - Dan Gonzalez, Principal, Avison Young

- David MacDonald, SVP Operations, K2M

- Joanne Lustre, Business Development Manager, Corning Life Science

Agricultural, environmental and industrial biotechnology: where biotech meets Virginia's largest industry

- Carrie Chenery, Executive Director, Shenandoah Valley Partnership

Unveiling the interactive, web-based Map of the Virginia Bioscience Community

- Sherri Halloran, Vice President Membership and Programs, Virginia Bio
11:00 12:45 Making Virginia best in class in commercializing university bioscience research Washingtonian I

The co-chairs of the Talent, Infrastructure and Strategy working groups formed from the Governor’s December 4 Summit will report and discuss findings and recommendations together with the Governor, Secretary of Commerce and Trade, and legislative leaders

- Cheryl Moore, Executive Vice President and Chief Operating Officer, Howard Hughes Medical Institute

- Richard Shannon, Executive Vice President for Health Affairs, University of Virginia

- James Powers, CEO, HemoShear

- Timothy Sands, President, Virginia Tech (by Michael Friedlander, Founding Executive Director, Virginia Tech Carilion Research Institute and Associate Provost for Health Sciences, Virginia Tech)

- Crystal Icenhour, CEO, Aperiomics

- Emanual "Chip" Petricoin III, University Professor and Co-Director, Center for Applied Proteomics and Molecular Medicine, George mason University
12:00 1:30 Networking Lunch Terrace
1:30 5:15 Governor's Forum on Bio and Big Data/Analytics Washingtonian

Welcome and Introduction - Knox Singleton, CEO, INOVA Health System

Governor Terry McAulliffe

Thought Leader: Jon White, Acting Deputy National Coordinator, CMO, Office of the National Coordinator for Health Information Technology (ONC) is at the forefront of the administration’s health IT efforts and is a resource to the entire health system to support the adoption of health information technology and the promotion of nationwide health information exchange to improve health care. ONC is organizationally located within the Office of the Secretary for the U.S. Department of Health and Human Services (HHS). ONC is the principal federal entity charged with coordination of nationwide efforts to implement and use the most advanced health information technology and the electronic exchange of health information and with NIH, FDA and NCI, the President’s Precision Medicine Initiative

Lightening Round 1

Thought Leader. Jason Paragas, Deputy Director for the Office of Mission Innovation at Lawrence Livermore National Laboratory. Dr. Paragas will discuss BAASiC: Biological Application in Advanced Strategic Computing, aka Pharma 2.0, an open consortium focusing data science on predictive biology, and share a vision of creating in silico biological systems capable of supporting all stages of target / drug discovery, development and testing, and informing the next generation of data science and computing architecture.

Lightening Round 2
3:00 3:15 Networking Break Rotunda
3:15 5:15 Governor's Forum on Bio and Big Data/Analytics - continued Washingtonian

Thought Leader: Yihong Yao, Director and Head of Pharmacogenomics and Bioinformatics Group, MedImmune. Dr. Yao will describe the ways big data/analytics is transforming the biopharmaceutical drug discovery and development, from discovery of targets and candidates, to the design and execution of clinical trials. Developments include the use of cutting edge genomics and genetics approaches to develop pharmacodynamics and predictive diagnostic markers to understand disease linkage, identify the right patient population for therapeutic intervention, unveil key drivers and understand the pathways of disease pathogenesis.

Lightening Round 3

Thought Leader: Paul Wallace, Chief Medical Officer and Senior Vice President for Clinical Translation, Optum Labs, Cambridge MA Paul Wallace, Chief Medical Officer and Senior Vice President for Clinical Translation, Optum Labs, Cambridge MA. Dr. Wallace will describe the opportunity for innovative, multi-partner, collaborations to accelerate breakthrough health care research, innovations and their clinical adoption by connecting diverse partners’ perspectives and expertise, pooling data, and creating and applying advanced analytics and visualization technology.

Lightening Round 4

Closing Discussion
5:15 5:30 Awards
5:30 7:30 Statewide Reception Terrace
7:30 9:30 Private Board and Bioscience Leaders Dinner - Invitation only Washingtonian I

Lightening Round Presenters

Aperiomics, Chantilly. This spin out of George Washington University’s Virginia Science and Technology Campus (and Computational Biology Institute) uses proprietary computational and visualization algorithms with next gen sequencing to describe a complete (5,000 organism) microbiome and identify pathogenic content from a single biological sample in a clinical timeframe, changing the paradigm for microbial diagnostics. Crystal R Icenhour, CEO and Keith Crandall, Director, GW Computational Biology Institute.

Biotherapeutics (BTI), Blacksburg, is a spin-off Company of the Virginia Bioinformatics Institute at Virginia Tech that combines computational modeling of immunological systems and pre-clinical and clinical validation to accelerate the development of new drugs for autoimmune and inflammatory diseases. Josep Bassaganya-Riera, President & CEO.

C3Nexus, Richmond. This startup’s products and services capture and analyze patient generated data, turning it into actionable advice for physicians and patients recovering at home from acute cardiac events, combining innovative home care support service and systems. Shaiv Kapadia MD and Nuno Valentine, Co-founders.

Global Genomics Group (G3), Richmond. G3 is engaged in the discovery and development of diagnostics and therapeutics in cardiovascular, cardio-metabolic, liver, and bone disease, using its up to 10,000 subject prospective study of full panomics and digitized imaging and clinical data. By leveraging molecular profiles of human health, G3 is developing a new standard to unravel the mysteries of human diseases. Shahid Shah, Chief Technology Officer.

Innovative Solutions Consortium (ISC), Leesburg. Winners of the National Innovation Challenge, ISC identified and engaged advanced analytics from US defense and security sectors to apply to massive clinical and research databases for the purpose of discovering new drug candidates for ALS (Lou Gehrig’s disease), in collaboration with the Robert Packard Center for ALS Research at Johns Hopkins, NIH and ATIEGO. Enrico Serafini, Director of Operations, Atigeo

Inova Translational Medicine Institute, Fairfax. ITMI is engaged in collecting and analyzing data on a scale unmatched by other genomic research labs to make important discoveries for the future of healthcare. In our groundbreaking studies, we are looking for answers to tough medical questions about childhood development, rare disorders and chronic diseases, including studies on: premature Birth, The First 1,000 Days of Life, Congenital Disorders, Type 2 Diabetes, Allergies and Autoimmune Disease and Heart Failure. John Niederhuber, Chief Executive Officer.

Noblis, Falls Church. The company’s “BioVelocity” is an extremely rapid comprehensive genomic analysis service and platform product. Headquartered in Northern Virginia, the company has several sites across Virginia including Danville, where Noblis houses its Cray XMT2 supercomputer and one of its two Torque clusters; remarkable advances made by Noblis in other fields such as visual analytics have applicability to bioscience and biomedicine. Dr. Gil Miller, VP and Chief Technology Officer, and Dr. Sterling Thomas, Director, Center for Applied High Performance Computing.

Northrop Grumman Information Systems, McLean. The company’s Health Division provides systems integration services and support to NIH, CDC, CMS and other public and private health sector organizations.Through its Personalized Healthcare Initiative, Northrop Grumman has developed tools and solutions which enable multi-source genetic and clinical health data to be integrated, analyzed and visualized to assist health researchers and healthcare systems in accelerating scientific discovery and improving healthcare effectiveness. Dr. Sam Shekar, CMO Health Division, Northrop Grumman Information Systems

Perthera, Inc., Mclean, is a personalized cancer therapy solutions company that democratizes precision medicine to cancer patients nationwide. Their precision medicine service is a turn-key system based on combining best-in-class molecular profiling that extend beyond genomics to “panomics”, along with cutting edge systems network informatics analysis of molecular data, clinical outcomes, therapy decisions, and clinical support data. Chip Petricoin, CSO, and Co-Director of the Center for Applied Proteomics and Molecular Medicine at George Mason University

Venebio, LLC, Richmond – Venebio develops innovative, predictive healthcare algorithms to improve the treatment of common chronic health conditions. aRx Statin Advisor, the first in a suite of novel, patent-pending, clinical decision support (CDS) tools, helps physicians select the most effective statin-dose combination for hypercholesterolemic patients, minimizing cost and time for patients to reach target LDL-C goal. Andrew Joyce, Chief Scientific Officer.

Virginia Tech Carilion Research Institute, Roanoke. Among the groundbreaking research leveraging data science performed at this 150 researcher Institute is the functional MRI global network arising from Dr. Read Montague's lab. This research network captures and analyzes image data on the functioning brain in unprecedented detail and volume, including a 5,000 subject longitudinal study of healthy volunteers worldwide, to uncover mechanisms and identify causes of disease and candidate therapies. Michael Friedlander, Founding Executive Director, and Associate Provost for Health Sciences, Virginia Tech.

Virginia Commonwealth University, Center for Clinical and Translational Research, Richmond. Major research university and health care system integrating patient data and applying bioinformatics to bring precision medicine to patients with cancer and other conditions and diseases. David Fenstermacher, VCU Chief Research Information Officer and Director of Biomedical Informatics for the Center for Clinical and Translational Research and the Chief Research Information Officer for the Massey Cancer Center.



Our Premium Partners

Sign up for our newsletter
800 E. Leigh St.  |  Richmond, Va 23219-1534  |  PH: 804.643.6360  |  Email Us
Stay Connected